Clifford Swan Investment Counsel LLC Acquires 49,494 Shares of UnitedHealth Group Incorporated $UNH

Clifford Swan Investment Counsel LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 86.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 107,012 shares of the healthcare conglomerate's stock after purchasing an additional 49,494 shares during the period. UnitedHealth Group comprises 1.2% of Clifford Swan Investment Counsel LLC's portfolio, making the stock its 23rd biggest position. Clifford Swan Investment Counsel LLC's holdings in UnitedHealth Group were worth $33,385,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the stock. Nuveen LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth $3,846,764,000. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. National Bank of Canada FI boosted its holdings in UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after buying an additional 847,054 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research note on Thursday, October 9th. Barclays increased their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a report on Thursday, October 9th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday, September 9th. Sanford C. Bernstein lifted their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 8th. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $385.13.

UnitedHealth Group Trading Down 1.1%

Shares of UnitedHealth Group stock opened at $361.29 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $327.21 billion, a PE ratio of 15.65, a P/E/G ratio of 2.36 and a beta of 0.47. The business's fifty day moving average is $335.48 and its two-hundred day moving average is $341.42.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.